Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Polycystic Ovary Syndrome 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Diabetes Mellitus, Type 2 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Glioblastoma 2Thyroid Nodule 1Renal Insufficiency 1Pancreatic Neoplasms 1Neoplasms, Adipose Tissue 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Kidney Failure, Chronic 1Insulin Resistance 1Infertility 1Glioma 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Body Weight 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 60Cyclophosphamide 60Busulfan 43Cyclosporine 41Mycophenolic Acid 40Peripheral Blood Stem Cell Transplantation 39Cytarabine 36Whole-Body Irradiation 34Antilymphocyte Serum 29Filgrastim 26Tacrolimus 24Methotrexate 24fludarabine 23Cord Blood Stem Cell Transplantation 22Radiotherapy 21Melphalan 20Etoposide 18Methylprednisolone 15Azacitidine 14Granulocyte Colony-Stimulating Factor 13Idarubicin 12Daunorubicin 11Thiotepa 10sargramostim 8Cyclosporins 8Clofarabine 7Arsenic Trioxide 7Transplantation 6Topotecan 6Mitoxantrone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anemia, Refractory, with Excess of Blasts × Sitagliptin Phosphate × Clear all
NCT00862719 2016-10-07

Sitagliptin Umbilical Cord Blood Transplant Study

Indiana University

Phase 2 Completed
29 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Lymphoma, Non-Hodgkin, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡